[ad_1]
"Some of the preparations for various diseases have so far been 100% and 80% or 90% matched, and the PSDF's budget savings have brought the majority of diseases to 100%", said Friday the Minister of Health. Veryga.
Deputy Minister of Health Kristina Garuolienė said that there is essentially a group of diseases where 100% of the drugs will not be reimbursed. – Cardiovascular diseases
"Medicines for the treatment of hypertension and other heart diseases will be reimbursed at 90%, and until now, they have been compensated up to 80%" , said K. Garuolienė
. , for diseases of the circulatory system and in cases of disorders of lipoprotein metabolism, instead of 80%. Determine 90 percent
Yosvydas Elinskas / 15 minute photo / Christina Garuolienė
The estimated additional expenses of the Mandatory Health Insurance Fund (PSDF) for these drugs would be about 3.6 mln. .
For infectious and parasitic diseases, endocrine diseases, nervous system, ocular, digestive, urobad, pregnancy and childbirth, conbad malformations, organ transplants and, in some cases, Compensation levels of 80 and 90% It is expected to increase up to 100%.
According to the department, this would cost an additional $ 4.6 million.
The Ministry of Health (SAM) says that the new drugs in the price list on Thursday, based on a new reciprocal drug, will be cheap, However, manufacturers are criticizing the shortening of the list of reimbursable drugs.
According to SAM, in the new price list, the "ceiling" of the premium, 100%. The compensation premium can not exceed EUR 4.11
The Ministry also claims that the new pricing of medicines and the reduction of prices of pharmaceutical companies have saved a considerable amount of extra budgetary and administrative costs. patients, thus starting to compensate for the active substances. New Active Ingredients: These drugs are intended for the treatment of end-stage pain in cancer, chronic lymphocytic leukemia, Hodgkin lymphoma, asthma, BRAF-free melanoma, ovarian and / or ovarian cancer, lung and bad cancer and other diseases. 19659015] Joshvydas Elinskas / Photo 15min / Aurelius Veryga "rel =" happy image "src =" https://s2.15min.lt/static/cache/NTcweCwsODEyMzY0LG9yaWdpbmFsLCxpZD00MDM5NjA4JmRhdGU9MjAxOCUyRjA3JTJGMTMsMzY0NjY3NDQ2Nw==/sveikatos-apsaugos-ministerijoje-ivyko-spaudos- konferencija-5b48598d82379.jpg "style =" width: auto; height: auto; "/>
Joshvydas Elinskas / Photo of 15min / Aurelius Veryga
The Ministry maintains that all active substances consuming patients remain in price, but pharmaceutical manufacturers point out that it There will be fewer drugs.According to the Association of Pharmaceutical Manufacturers, 200,000 people will have to change their habits.With the introduction of the new procedure, manufacturers have decreased, while in the tariff, nearly One-quarter of the compensatory medications left to 200,000 patients have been treated with cardiovascular, pulmonary, central nervous system, oncology and other illnesses, they need to switch drugs, "said Rasa Bričkienė, director of the Pharmaceutical Manufacturers Association.
The Minister of Health said that until now, a proportion of patients were paying five euros more per month.
"The fact that the patient has a habit of buying a brand name, where two active substances are compressed into one tablet is more of a psychological condition but not an active substance or a treatment", said the minister at a press conference. 19659021] "I had some patients sit on a site to take and compare the prices of the drugs used to treat blood pressure, where it is compressed into one tablet and two tablets, but the same dose, the same active ingredient , month ", – said the minister.
He noted that the activist
"There are some patients who do not want to get out the two pills so that we pay five euros, especially the retirees for whom these five euros – a lot of money. money. "- A.Veryga.
Pharmacists say a total of 1950 drugs were submitted in the initial price list, while 1584 were approved, since 366 drugs did not meet the requirements of the procedure. More than 200 drugs that do not comply with the government order remain due to the uniqueness and the need for treatment for patients.
Josvydas Elinskas / 15min photos / Aurelius Veryga
Director of the Innovative Pharmaceutical Industry Association Agnė Gaižauskienė states that the new price list limits the allocation of more than half a dozen unprocessed drugs to new patients.
"We agree that the optimization of the price of drugs is necessary to ensure the best access to advanced treatment.They need the treatment.However, we see that the new prescription does not guarantee that – a lot of patients will be limited to the right to receive the necessary drugs, "said A. Gaižauskienė
According to the press release of the Association, some of the patients will decrease the payment of drugs. will have to change their usual medications. In addition, some drugs will only be available for continuous treatment, which means that new patients will no longer be able to receive the same medication.
